BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 35034753)

  • 1. T cells, α-synuclein and Parkinson disease.
    Garretti F; Monahan C; Sette A; Agalliu D; Sulzer D
    Handb Clin Neurol; 2022; 184():439-455. PubMed ID: 35034753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cells from patients with Parkinson's disease recognize α-synuclein peptides.
    Sulzer D; Alcalay RN; Garretti F; Cote L; Kanter E; Agin-Liebes J; Liong C; McMurtrey C; Hildebrand WH; Mao X; Dawson VL; Dawson TM; Oseroff C; Pham J; Sidney J; Dillon MB; Carpenter C; Weiskopf D; Phillips E; Mallal S; Peters B; Frazier A; Lindestam Arlehamn CS; Sette A
    Nature; 2017 Jun; 546(7660):656-661. PubMed ID: 28636593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodegeneration by α-synuclein-specific T cells in AAV-A53T-α-synuclein Parkinson's disease mice.
    Karikari AA; McFleder RL; Ribechini E; Blum R; Bruttel V; Knorr S; Gehmeyr M; Volkmann J; Brotchie JM; Ahsan F; Haack B; Monoranu CM; Keber U; Yeghiazaryan R; Pagenstecher A; Heckel T; Bischler T; Wischhusen J; Koprich JB; Lutz MB; Ip CW
    Brain Behav Immun; 2022 Mar; 101():194-210. PubMed ID: 35032575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells.
    Garretti F; Agalliu D; Lindestam Arlehamn CS; Sette A; Sulzer D
    Front Immunol; 2019; 10():303. PubMed ID: 30858851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FK506 reduces neuroinflammation and dopaminergic neurodegeneration in an α-synuclein-based rat model for Parkinson's disease.
    Van der Perren A; Macchi F; Toelen J; Carlon MS; Maris M; de Loor H; Kuypers DR; Gijsbers R; Van den Haute C; Debyser Z; Baekelandt V
    Neurobiol Aging; 2015 Mar; 36(3):1559-68. PubMed ID: 25660193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-dependent neurodegeneration and neuroinflammation in a genetic A30P/A53T double-mutated α-synuclein mouse model of Parkinson's disease.
    Rauschenberger L; Behnke J; Grotemeyer A; Knorr S; Volkmann J; Ip CW
    Neurobiol Dis; 2022 Sep; 171():105798. PubMed ID: 35750147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons.
    Decressac M; Mattsson B; Lundblad M; Weikop P; Björklund A
    Neurobiol Dis; 2012 Mar; 45(3):939-53. PubMed ID: 22182688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal Presentation of Antigen and Its Possible Role in Parkinson's Disease.
    Hobson BD; Sulzer D
    J Parkinsons Dis; 2022; 12(s1):S137-S147. PubMed ID: 35253783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration.
    Cebrián C; Zucca FA; Mauri P; Steinbeck JA; Studer L; Scherzer CR; Kanter E; Budhu S; Mandelbaum J; Vonsattel JP; Zecca L; Loike JD; Sulzer D
    Nat Commun; 2014 Apr; 5():3633. PubMed ID: 24736453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial Parkinson mutant alpha-synuclein causes dopamine neuron dysfunction in transgenic Caenorhabditis elegans.
    Kuwahara T; Koyama A; Gengyo-Ando K; Masuda M; Kowa H; Tsunoda M; Mitani S; Iwatsubo T
    J Biol Chem; 2006 Jan; 281(1):334-40. PubMed ID: 16260788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
    Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
    J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain.
    Devi L; Raghavendran V; Prabhu BM; Avadhani NG; Anandatheerthavarada HK
    J Biol Chem; 2008 Apr; 283(14):9089-100. PubMed ID: 18245082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions among alpha-synuclein, dopamine, and biomembranes: some clues for understanding neurodegeneration in Parkinson's disease.
    Rochet JC; Outeiro TF; Conway KA; Ding TT; Volles MJ; Lashuel HA; Bieganski RM; Lindquist SL; Lansbury PT
    J Mol Neurosci; 2004; 23(1-2):23-34. PubMed ID: 15126689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration.
    Soria FN; Engeln M; Martinez-Vicente M; Glangetas C; López-González MJ; Dovero S; Dehay B; Normand E; Vila M; Favereaux A; Georges F; Lo Bianco C; Bezard E; Fernagut PO
    Hum Mol Genet; 2017 Jul; 26(14):2603-2615. PubMed ID: 28520872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease.
    Gründemann J; Schlaudraff F; Haeckel O; Liss B
    Nucleic Acids Res; 2008 Apr; 36(7):e38. PubMed ID: 18332041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
    Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Synuclein induces Th17 differentiation and impairs the function and stability of Tregs by promoting RORC transcription in Parkinson's disease.
    Li J; Zhao J; Chen L; Gao H; Zhang J; Wang D; Zou Y; Qin Q; Qu Y; Li J; Xiong Y; Min Z; Yan M; Mao Z; Xue Z
    Brain Behav Immun; 2023 Feb; 108():32-44. PubMed ID: 36343753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.
    Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS
    J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine-mediated oxidation of methionine 127 in α-synuclein causes cytotoxicity and oligomerization of α-synuclein.
    Nakaso K; Tajima N; Ito S; Teraoka M; Yamashita A; Horikoshi Y; Kikuchi D; Mochida S; Nakashima K; Matsura T
    PLoS One; 2013; 8(2):e55068. PubMed ID: 23457458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age- and α-Synuclein-Dependent Degeneration of Dopamine and Noradrenaline Neurons in the Annual Killifish Nothobranchius furzeri.
    Matsui H; Kenmochi N; Namikawa K
    Cell Rep; 2019 Feb; 26(7):1727-1733.e6. PubMed ID: 30759385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.